Not for human or veterinary use 490 in stock Retatrutide REPORTS POSTED IN PRODUCT GALLERY Current Batch: 11031-007 Test Date April 2nd, 2026 Purity: 99.969% Net Content: 21.30mg Cap Color: Dark Blue Heavy Metal Testing: Lead (Pb): Negative Cadmium (Cd): Negative Arsenic (As): Negative Mercury (Hg): Negative Microbial Sterility Screen: No growth Endotoxin Safety Screen: PASS Current Batch: 11031-006 Test Date: Jan 29th, 2025 Purity: 99.484 Net Content: 20.46 mg Retatrutide ( GLP-RT) Cap Color: Dark Blue Endotoxin Test: PASS ( Posted in the Product Gallery) All analyses are conducted for research purposes and performed in duplicate in accordance with USP guidelines
Two scoops, your choice of milk, freeze overnight, spin
Next, an ice-cold extraction buffer (1:1 MeOHTris buffer + an internal standard [d 4 -AEA]) was added to the samples
Description Retatrutide (GLP-3) 15mg is a synthetic triple receptor agonist peptide studied in preclinical and clinical research for its interactions with GLP-1, GIP, and glucagon receptor (GLP-1/GIP/GCGR) binding and downstream signaling pathway analysis
Short-term caloric restriction induced bone loss in both axial and appendicular bones by increasing adiponectin
(2009) 296:E41521
